MassBio
  • Member Directory
  • Events
  • Purchasing & Rewards
  • Discover
  • Why Massachusetts
  • Careers
  • News
  • About
  • Become a Member Company
  • Log In / Create Account
  • @MassBio
  • LinkedIn
Discover
  • Knowledge Base
  • MassCONNECT
  • Policy & Advocacy
  • Diversity
  • Funding Opportunities
  • Post Knowledge

Knowledge Base

Articles 1 - 8 of 8
Situation Analysis and Opportunity Assessment New Perspectives, Inc. February 8, 2019
  • Access,
  • Startups,
  • Value

A successful product development strategy requires a comprehensive understanding of the market environment. Learn more… Read More

Member Only
Conducting Feasibility for a New Clinical Trial April 10, 2018 in White Papers,
  • Access,
  • Innovation,
  • Policy

What does the word “feasibility” mean to you? It may seem like a simple question, but I have found that “feasibility” has many interpretations within the clinical research industry. When we work with Read More

Member Only
Not Just Tiny Humans: Considerations for Conducting Pediatric Clinical Trials April 3, 2018 in White Papers,
  • Access,
  • Advocacy,
  • Patent Reform,
  • Policy,
  • Value

When it comes to the conduct of pediatric clinical trials, there are number of things you need to consider in order to ensure the successful conduct of a study. While we can’t predict the outcome, pla Read More

Member Only
President Trump and the Big 6 Tax Plan: What Can We Expect? WithumSmith+Brown November 1, 2017 in Advisories,
  • Access,
  • Advocacy,
  • Alerts,
  • Economic Impact,
  • Federal Issues,
  • State Issues,
  • Value

Earlier this week, President Trump and the “Big 6” Republican leaders announced their long-awaited tax plan, setting the following goals for the proposal. Read More

Member Only
Clinical Trials in Australia: Industry Capability Report Australian Trade and Investment Commission August 9, 2017 in White Papers,
  • Access,
  • Innovation,
  • Startups

Australia is regarded as one of the best places in the world to conduct clinical trials. Download the report for case studies with leading pharma companies to learn why. Read More

Member Only
Business success in the life sciences: an investment banker’s perspective Outcome Capital June 28, 2017 in White Papers,
  • Access,
  • Deals,
  • Drug Cost,
  • Economic Impact,
  • Innovation,
  • Workforce Development

As we are passionate about bringing paradigm-shifting technologies to patients, we were excited by the opportunity to facilitate transatlantic collaborations between Boston’s biotech hub and the life Read More

Member Only
Platforms versus products in the life sciences sector Outcome Capital June 23, 2017
  • Access,
  • Deals,
  • Drug Cost,
  • Economic Impact,
  • FDA,
  • Funding,
  • Innovation

In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk by allocating time and money in a capital Read More

Member Only
FREE WEBINAR: Communicating innovation to payers and policy makers Cello Health November 23, 2016 in Presentation & Video Library,
  • Access,
  • Funding,
  • Policy,
  • Value

Involving public affairs early during the development and commercialization process of a new asset is critical to success when demonstrating value to payers and policy makers. Learn how to communicate value during this... Read More

Member Only
Articles 1 - 8 of 8

Category

  • All
  • White Papers
  • Advisories
  • Research Papers
  • Checklists
  • Training Sessions
  • Presentation & Video Library
Popular Tags
  • Innovation43,
  • Value34,
  • Policy31,
  • Workforce Development22,
  • Alerts19,
  • Advocacy18,
  • Federal Issues17,
  • Startups17,
  • Economic Impact16,
  • Biomanufacturing14,
  • Home
  • Legal
  • Contact
  • Get Email Updates
  • @MassBio
  • LinkedIn
  • Facebook
  • YouTube
Massachusetts Biotechnology Council 300 Technology Square, 8th Floor
Cambridge, MA 02139
617.674.5100

© 2019 All Rights reserved Powered by Getfused